INIS
eosinophils
78%
mice
50%
antibodies
35%
in vivo
28%
blood
28%
tissues
21%
administration
21%
apoptosis
21%
levels
14%
humans
14%
in vitro
14%
receptors
14%
reduction
14%
viability
14%
sialic acid
14%
data
7%
molecules
7%
transgenic mice
7%
cross-linking
7%
ligands
7%
leukemia
7%
doses
7%
tyrosine
7%
lectins
7%
immunoglobulins
7%
Medicine and Dentistry
Sialic Acid Binding Immunoglobulin Like Lectin
100%
Eosinophil
78%
Antibody
35%
Blood
28%
Programmed Cell Death
21%
Tissues
21%
In Vitro
14%
Diseases
7%
Receptor
7%
Transgenic Mouse
7%
Combination Therapy
7%
Lipocortin 5
7%
Single Drug Dose
7%
Eosinophilic
7%
Hypereosinophilia
7%
Chronic Eosinophilic Leukemia
7%
Ligand Binding
7%
Paralogy
7%
Sialic Acid
7%
Immune System Receptors
7%
Family
7%
Human
7%
Immunoreceptor Tyrosine Based Inhibition Motif
7%
Immunology and Microbiology
Sialic Acid Binding Immunoglobulin Like Lectin
100%
Eosinophil Granulocyte
78%
Monospecific Antibody
35%
Mouse
28%
Apoptosis
21%
Tissues
21%
Mouse Model
14%
Reduction (Chemistry)
14%
Wild Type
7%
Cross Linking
7%
Wild Type Mouse
7%
Human
7%
Paralogy
7%
Transgenic Mouse
7%
Ligand Binding
7%
Molecule
7%
Immunoreceptor Tyrosine-Based Inhibitory Motif
7%
Immune Receptor
7%
Biochemistry, Genetics and Molecular Biology
Mouse
28%
Apoptosis
21%
Reduction (Chemistry)
14%
Wild Type
7%
Transgenic Mouse
7%
Molecule
7%
Wild Type Mouse
7%
Human
7%
Single Drug Dose
7%
Cross-Link
7%
Paralogy
7%
Immune Receptors
7%
Sialic Acid
7%
Annexin
7%
Immunoreceptor Tyrosine-Based Inhibitory Motif
7%